Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Asthma · Multiple Sclerosis · TEVA

Teva Pharma

Teva Pharma GmbH

Teva Pharma clinical programs — 473 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV HQ
126 Employees
Public company Type
TEVA · NYSE Ticker
Company details
Status
Public
HQ
10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
Employees
126
Programs
473
Drugs
447
Patents
454
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Teva Pharma projects

473 ClinicalTrials.gov programs sponsored by Teva Pharma.

Teva Pharma has 473 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

473 programs

Clinical programs

Page 7 of 10

  1. Arsenic trioxide

    Teva Pharma GmbH

    Chronic Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  2. Azithromycin

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  3. Azithromycin 600 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  4. BDP HFA Nasal Aerosol

    Teva Pharma GmbH

    Allergic Rhinitis

    phase 1 small molecule completed

    1 trial

  5. BUSPAR® 30 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  6. Beclomethasone dipropionate BAI

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  7. Benazepril HCl 40 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  8. Bicalutamide

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  9. Buprenorphine

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  10. Bupropion HCl

    Teva Pharma GmbH

    Depressive Disorder

    phase 1 small molecule terminated

    1 trial

  11. C33237/1099

    Teva Pharma GmbH

    Pain

    phase 1 small molecule completed

    1 trial

  12. C33237/1106

    Teva Pharma GmbH

    Pain

    phase 1 small molecule completed

    1 trial

  13. CD56-Enriched Donor Lymphocyte Infusion

    Teva Pharma GmbH

    Multiple Myeloma

    phase 1 mab completed

    1 trial

  14. CEP-11981 (kinase inhibitor)

    Teva Pharma GmbH

    Cancer

    phase 1 small molecule completed

    1 trial

  15. CEP-26401

    Teva Pharma GmbH

    Cognitive Impairment

    phase 1 small molecule completed

    1 trial

  16. CEP-37250/KHK2804

    Teva Pharma GmbH

    Solid Tumour

    phase 1 small molecule completed

    1 trial

  17. CEP-37251

    Teva Pharma GmbH

    Bone Loss

    phase 1 small molecule terminated

    1 trial

  18. CEP-37440

    Teva Pharma GmbH

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  19. CEP-9722

    Teva Pharma GmbH

    Solid Tumors or Mantle Cell Lymphoma

    phase 1 small molecule completed

    1 trial

  20. CEP-9722

    Teva Pharma GmbH

    Solid Tumor

    phase 1 small molecule completed

    1 trial

  21. Carvedilol 25 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  22. Cefadroxil 500 mg Capsules

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  23. Cefdinir Capsules 300 mg

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  24. Cefdinir for oral suspension 250 mg/5mL

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  25. Cefprozil for oral suspension 250 mg/5 mL

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  26. Cefzil® 500 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  27. Cilostazol 100 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  28. Cilostazol 50 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  29. Clarithromycin

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  30. Clarithromycin ER 500 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  31. Clindamycin 300 mg capsule

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  32. Custirsen

    Teva Pharma GmbH

    Cardiac Conduction and Repolarization

    phase 1 small molecule completed

    1 trial

  33. Custirsen, paclitaxel and carboplatin

    Teva Pharma GmbH

    Cancer

    phase 1 small molecule completed

    1 trial

  34. Delayed Release 6 mercaptopurine

    Teva Pharma GmbH

    Crohns Disease

    phase 1 small molecule completed

    1 trial

  35. Desmopressin Acetate 0.2 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial

  36. Desogestrel/ethinyl estradiol and ethinyl estradiol

    Teva Pharma GmbH

    Follicle Development

    phase 1 small molecule completed

    1 trial

  37. Dexmethylphenidate Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  38. Divalproex Sodium

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials

  39. Donepezil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  40. Donepezil Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  41. Doxycycline Monohydrate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  42. Drospirenone/Ethinyl Estradiol (Gianvi®)

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  43. Estradiol/Norethindrone acetate

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  44. Famciclovir 500 mg Tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  45. Fexofenadine 180 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  46. Finasteride 5 mg tablets

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  47. Fluoxetine Hydrochloride

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials

  48. Fluticasone Propionate MDPI

    Teva Pharma GmbH

    Asthma

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Teva Pharma have?

473 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.